Authors


Alessandro Ghidini, MD

Latest:

SMFM Consult Series #60: Management of pregnancies resulting from IVF

This Consult discusses the management of pregnancies achieved with in vitro fertilization and provides recommendations based on the available evidence.


Madeleine Mendelow

Latest:

Psychological reflections on miscarriage

When helping patients in the hardest moments of their lives, it is important to have empathy for them—and for ourselves.


Jhenette Lauder, MD

Latest:

Society for Maternal-Fetal Medicine Consult Series #50: The role of activity restriction in obstetric management

Little evidence supports the routine use of activity restriction for preterm birth and other obstetric conditions, and some data indicate adverse impact on obstetric outcomes.


Abira Afzal Choudhry, MD

Latest:

How to help adolescents choose the right contraceptive

Discover effective counseling techniques and overcome barriers to empower adolescents in making informed decisions about contraception, fostering trust, confidentiality, and autonomy in reproductive health care.


Natalie DiCenzo, MD

Latest:

2024 contraceptive updates

Find out what’s new and what this means for your practice.


Sarah Lassey, MD

Latest:

Managing fetal sex discordance in cfDNA

This article presents a clinical algorithm and four cases to consider.




June Hoi Ka Ng, MD

Latest:

Fresh ideas, workarounds during pandemic can increase access to contraception

The pandemic has forced us to get more creative in managing patients’ needs, especially when it comes to contraception


Yevgenia Y. Fomina, MD

Latest:

How can we prevent pregnancy-related deaths?

Interventions before and after birth can reduce the rising maternal mortality ratio.


Michael Krychman, MD

Latest:

What are the benefits of DHEA?

Anna Cabeca, DO, FACOG, discusses dehydroepiandrosterone and associated misunderstandings.


Jessica Hergert

Latest:

Immunotherapy approvals shine light on need for molecular testing in endometrial cancer

Sarah Lee, MD, MBA, discusses the use of checkpoint inhibitors in endometrial cancer, research regarding the association between MSI-H, dMMR, and TMB-H disease, and the importance of broad molecular testing to ensure all eligible patients are appropriately matched to immunotherapeutic options.


Katherine D. Crist, MD

Latest:

Perspectives on global women’s mental health

This diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.



Wendy Satmary, MD

Latest:

A deep dive into devices for sexual health

Gynecologic providers should feel more comfortable proactively addressing the sexual well-being of their patients.


John Jesitus

Latest:

Male contraception: Moving beyond missteps, misconceptions

After decades of disappointments, a new generation of male contraceptives is under development and expected to enable men to share the contraceptive burden with their female partners.


Rajesh Voddiraju

Latest:

How digital tools can help providers collect payment

It is essential that providers obtain the payments they are owed as quickly as reasonably possible, ensure payments are accurate and completely captured, and minimize costs to collect payments


Eve Valera, PhD

Latest:

Violence against women and acquired brain injuries

Violence against women and resulting traumatic brain injuries increased during the COVID-19 pandemic.


Harris Eyre, MD, PhD

Latest:

Mind-body resilience for women: A focus on depression

Here’s why we should be paying special attention to women’s depression treatment.


Katie Hobbins

Latest:

AAP recommends using non-stigmatizing terminology to discuss substance use

Rachel H. Alinsky, MD, MPH, FAAP, spoke with Contemporary Pediatrics® about her newly released AAP policy statement advocating for the use of medically accurate, person-first terminology when discussing substance use.



Jonah Feldman

Latest:

Survival benefit for chemotherapy addition demonstrated for premenopausal patients with HR+/HER2– breast cancer

Investigators of the SWOG S1007 RxPONDER trial found a statistically significant improvement in invasive disease-free survival and distant relapse-free survival in premenopausal women who received adjuvant chemotherapy.


Maggie Tibbitt

Latest:

Retifanlimab shows promising antitumor activity in advanced endometrial cancer

Retifanlimab demonstrated encouraging antitumor activity with favorable tolerability in patients with recurrent microsatellite instability–high or mismatch repair deficient endometrial cancer, according to data from the phase 1 POD1UM-101 trial.


Linda Stocum

Latest:

STDs and dermatologic symptoms

Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases (STDs) to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.


Jamie O. Lo, MD

Latest:

Impact of marijuana: Frequently asked questions

With growing public endorsement of the potential benefits of marijuana, it is important for health care providers to effectively counsel patients regarding its effects on fertility and future offspring.


Julia Malits

Latest:

Beware of “forever chemicals”

Counsel pregnant and breastfeeding patients about dangers from exposure to PFAS.


Jessica Ayre

Latest:

HIPAA mistakes to avoid when texting patients

While texting can make things a lot easier (and more profitable), it can also be easy to unknowingly violate HIPAA regulations.


Lindsey Carr, Editor

Latest:

In case you missed it: January 16 to January 20

Take a look back at this week's top stories.


Erin O'Brien

Latest:

Study examines best practices for managing perinatal depression

Recommendations are often vague, contradictory, according to investigators.


Santosh Pandipati, MD

Latest:

Panel discussion: Impacts of climate change on women's health

Senior Editor Angie DeRosa sat down Drs. Bekkar, DeNicola, Pandipati and Abel to discuss findings from a recent study on the association with air pollution and heat exposure with adverse obstetrical outcomes, such as preterm birth and stillbirth.

© 2025 MJH Life Sciences

All rights reserved.